- Home
- IMNM vs NBBK Comparison
IMNM vs NBBK Comparison
Compare IMNM & NBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- NBBK
- Stock Information
- Founded
- IMNM 2006
- NBBK 1892
- Country
- IMNM United States
- NBBK United States
- Employees
- IMNM N/A
- NBBK N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- NBBK
- Sector
- IMNM Health Care
- NBBK
- Exchange
- IMNM Nasdaq
- NBBK Nasdaq
- Market Cap
- IMNM 748.3M
- NBBK 661.3M
- IPO Year
- IMNM 2020
- NBBK N/A
- Fundamental
- Price
- IMNM $8.75
- NBBK $16.27
- Analyst Decision
- IMNM Strong Buy
- NBBK Buy
- Analyst Count
- IMNM 5
- NBBK 1
- Target Price
- IMNM $26.40
- NBBK $22.00
- AVG Volume (30 Days)
- IMNM 874.4K
- NBBK 355.1K
- Earning Date
- IMNM 08-11-2025
- NBBK 07-23-2025
- Dividend Yield
- IMNM N/A
- NBBK N/A
- EPS Growth
- IMNM N/A
- NBBK 421.39
- EPS
- IMNM N/A
- NBBK 1.18
- Revenue
- IMNM $10,938,000.00
- NBBK $169,131,000.00
- Revenue This Year
- IMNM N/A
- NBBK N/A
- Revenue Next Year
- IMNM $349.38
- NBBK N/A
- P/E Ratio
- IMNM N/A
- NBBK $13.82
- Revenue Growth
- IMNM N/A
- NBBK 27.71
- 52 Week Low
- IMNM $5.15
- NBBK $14.20
- 52 Week High
- IMNM $16.81
- NBBK $21.05
- Technical
- Relative Strength Index (RSI)
- IMNM 48.43
- NBBK 41.68
- Support Level
- IMNM $9.02
- NBBK $16.01
- Resistance Level
- IMNM $9.91
- NBBK $17.05
- Average True Range (ATR)
- IMNM 0.55
- NBBK 0.41
- MACD
- IMNM -0.08
- NBBK -0.02
- Stochastic Oscillator
- IMNM 9.37
- NBBK 51.71
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About NBBK NB Bancorp Inc.
NB Bancorp Inc operates as the holding company of Needham Bank. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate and multifamily loans, one- to four-family residential real estate loans, construction and land development loans, commercial and industrial loans, and consumer loans.